Who is sponsoring NCT05088720?

NCT05088720 is sponsored by Aswan University Hospital.

What condition does NCT05088720 study?

NCT05088720 studies Miscarriage.

What drugs are being tested in NCT05088720?

Interventions: misoprostol 800 µg, misoprostol 400 µg.

What is the status of NCT05088720?

NCT05088720 is currently UNKNOWN.

Last reviewed 2021-10-22 · How we verify

Misoprostol for Management of Women With an Incomplete Miscarriage

NCT05088720 NA UNKNOWN

Miscarriage is defined as the spontaneous loss of a pregnancy before 24 weeks gestation, that is, before fetal viability. The clinical signs of miscarriage are usually vaginal bleeding associated with abdominal pain and cramping. The miscarriage is named 'complete' or 'incomplete' according to whether or not tissues are retained in the uterus. If a woman has minimal bleeding but her cervix is closed, this is known as a 'threatened miscarriage. However; if the pregnancy is still inside the uterus but the cervix is open, this is described as an 'inevitable miscarriage', which it will not usually be possible to save the fetus.

Details

Lead sponsor	Aswan University Hospital
Phase	NA
Status	UNKNOWN
Enrolment	200
Start date	Mon Nov 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Mar 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Miscarriage

Interventions

misoprostol 800 µg
misoprostol 400 µg

Countries

Egypt